Atlas Trials

A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels

Clinical trial NCT00271557 · COMPLETED

Trial details

NCT number
NCT00271557
Sponsor
Scios, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Heart Failure, CongestiveHeart Decompensation
Start date
1997-01-01
Enrollment
305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.